Addressing Challenges in Managing Patients Receiving Oral Therapies for HR+, HER2- Breast Cancer

Increased use of oral therapies means more freedom for patients with cancer, but also can lead to increased risks. CANCER BUZZ spoke to Tammy Smith, Family Nurse Practitioner for INOVA Fairfax Hospital in Falls Church, VA, and Dr. Pearman Parker, Assistant Professor for the University of Arkansas for Medical Sciences in Little Rock, AR. Hear how to educate patients and their caregivers about the risks and benefits to oral therapies for breast cancer. This is the second episode in a three-part series on breast cancer.   Tammy R. Smith, FNP Family Nurse Practitioner INOVA Fairfax Hospital Falls Church, VA   Pearman Parker, PhD, MPH, RN, PMH-BC Assistant Professor University of Arkansas for Medical Sciences Little Rock, AR Resources: Addressing Challenges in Oral Therapies for HR+, HER2- Breast Cancer Resource Library for HR+, HER- Breast Cancer Evolving Standards of Care for Advanced HER2+ Breast Cancer Metastatic Breast Cancer Project